Micronutrient and Additive Modifications May Optimize Diet To Health
Region Skane
70 participants
Apr 2, 2024
INTERVENTIONAL
Conditions
Summary
This is a prospective clinical intervention trial where patients with moderately active ulcerative colitis are randomized to either normal healthy diet or a diet with elimination of emulsifying agents within the E 400-group with special respect to carragenan, CMC and polysorbates. At study start and end after one month their diet, clinical characteristics and microbiota will be analysed. The hypotheses are that their disease activity measured with calprotectin and their microbiota will improve after intervention.
Eligibility
Inclusion Criteria3
- Ulcerative colitis,
- Moderately active
- Stable medication
Exclusion Criteria7
- Severe disease
- Recent surgery
- Proctitis
- Pregancy
- Treatment with antibiotics
- Difficulties in understanding the information about the study
- Multimorbidity that makes it impossible to participate
Interventions
These patients will be given advice about a normal healthy diet.
Patients in the intervention group will be given advice how to eliminate E440 additives with regard to carragenan, CMC and polysorbates.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05743374